Normal human polyclonal immunoglobulins for intravenous use significantly delay hyperacute xenograft rejection.
Latremouille
C
C
Laboratoire d'étude des greffes et prothèses cardiaques, Hôpital Broussais, Paris, France.
Haeffner-Cavaillon
N
N
Goussef
N
N
Mandet
C
C
Hinglais
N
N
Bruneval
P
P
Bariety
J
J
Carpentier
A
A
Glotz
D
D
D000208:Acute Disease; D000818:Animals; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival; D006168:Guinea Pigs; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D051381:Rats; D011917:Rats, Inbred Lew; D013997:Time Factors; D014183:Transplantation, Heterologous; D016042:Transplantation, Heterotopic
D016756:Immunoglobulins, Intravenous